2022
DOI: 10.21037/jovs-20-110
|View full text |Cite
|
Sign up to set email alerts
|

Aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium to avoid the prosthesis-patient mismatch of a severely obese 57-year-old patient—a case report

Abstract: Aortic valve repair is the gold standard for aortic valve diseases and it is mandatory, every time it is possible, to spare the valve, especially in adults. In non-repairable aortic valves, the most common treatment is replacement with valve prostheses. Despite the risk of reoperation, bioprosthesis are often implanted in non-elderly adults. The durability of the bioprostheses in youngers is lower than in the elderlies. Immune reaction, shear stress and calcium metabolism can play a fundamental role in degener… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 6 publications
(6 reference statements)
0
5
0
Order By: Relevance
“…There have been conflicting outcomes in Baird et al 33 when employing autologous pericardium for aortic valve surgery. Albertini et al 34 presented their long-term outcomes of aortic valve replacement utilizing autologous pericardium treated in 0.2% glutaraldehyde for 10 minites with a 33% reoperation rate. In a similar treatment plan to that described by Ozaki, Carotti 38 reported the long-term outcomes of the leaflet extension approach employing autologous pericardium.In that series, a 15% reoperation rate after 7 years was seen in 41 patients with a mean age of 32 years, indicating that autologous pericardial patches may outlast bioprosthetic aortic valves in younger individuals.…”
Section: Discussionmentioning
confidence: 99%
“…There have been conflicting outcomes in Baird et al 33 when employing autologous pericardium for aortic valve surgery. Albertini et al 34 presented their long-term outcomes of aortic valve replacement utilizing autologous pericardium treated in 0.2% glutaraldehyde for 10 minites with a 33% reoperation rate. In a similar treatment plan to that described by Ozaki, Carotti 38 reported the long-term outcomes of the leaflet extension approach employing autologous pericardium.In that series, a 15% reoperation rate after 7 years was seen in 41 patients with a mean age of 32 years, indicating that autologous pericardial patches may outlast bioprosthetic aortic valves in younger individuals.…”
Section: Discussionmentioning
confidence: 99%
“…In particular the physiological movement of the aortic annulus through the cardiac cycle after AVNeo has to be highlighted [ 5 , 12 ]. Due to the 10–15-year durability of conventional bioprostheses fabricated from bovine pericardium, especially for younger patients that have the risk for necessary re-operation, the use of autologous pericardium is a promising alternative [ 2 , 13 ]. A discussed increase of free margin lengths of the cusps in AVNeo can be the basis for a greater utility even for pediatric populations with continued aortic annular growth [ 1 , 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…A discussed increase of free margin lengths of the cusps in AVNeo can be the basis for a greater utility even for pediatric populations with continued aortic annular growth [ 1 , 14 , 15 ]. But also adult or elderly patients with an increased risk of prosthesis-patient mismatch e. g. with extreme anatomical specificities may profit from the surgical technique using autologous material [ 5 , 13 ]. Nevertheless, in 2022 a first case with the need for re-operation after AVNeo was published describing the calcification of the cusps at the annulus positions [ 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…Albertini et al (1) described their experience with aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium in a severely obese 57-year-old female patients with history of acute articular rheumatism in her childhood, who rapidly showed signs of dyspnoea and angina following moderate physical exertion a month prior to the operation. TTE revealed severe aortic stenosis, which was later confirmed by TEE.…”
mentioning
confidence: 99%
“…The authors stated that this technique is a safe and effective treatment choice for aortic valve disease in non-elderly patients and is a feasible alternative to aortic valve replacement with biological or mechanical valve as well as the Ross procedure. Yet, randomized trials and larger observational studies are needed in the future to confirm these findings as evidence in the literature on use of autologous pericardium is currently limited (1).…”
mentioning
confidence: 99%